CA Patent

CA2556089A1 — Method for enhancing the bioavailability of ospemifene

Assigned to Hormos Medical Ltd · Expires 2005-08-25 · 21y expired

What this patent protects

This invention relates to a method for enhancing the bioavailability of ospemifene or a geometric isomer, a stereoisomer, a pharmaceutically active salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with th…

USPTO Abstract

This invention relates to a method for enhancing the bioavailability of ospemifene or a geometric isomer, a stereoisomer, a pharmaceutically active salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food. The invention also relates to the treatment or prevention of osteoporosis, skin atrophy, epithelial and mucosal atrophy, as well as to treatment or prevention of urinary or vaginal symptoms.

Drugs covered by this patent

Patent Metadata

Patent number
CA2556089A1
Jurisdiction
CA
Classification
—
Expires
2005-08-25
Drug substance claim
No
Drug product claim
No
Assignee
Hormos Medical Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.